Lumacaftor/Ivacaftor Drug Combo for CF Patients With Two Copies Of F508del Mutation Gains U.S., European Approval
Cystic Fibrosis, News
Vertex Pharmaceuticals Incorporated has announced its submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and a Marketing Authorization Application (MAA) to the European ... Read more